Last updated: 2026-09-06 13:19:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
BioAtla, Inc. (BCAB) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $1.77, with a market capitalisation of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.97 to $71.50. This page covers its latest market performance, valuation, price trends and company information.
-- | |
$1.58 | |
$3,831.50 | |
$0.97 | |
$3.14 | |
1.01M | |
-- | |
-- | |
$71.50 | |
$0.97 | |
-- | |
-- |
BioAtla, Inc. (BCAB) last closed at $3.14 as of 2026-08-29 00:00:00, unchanged from the previous close of $3.14.
During the latest regular trading session, BCAB traded between $0.97 and $3,831.50, with a volume of 1.01M shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, BioAtla, Inc. (BCAB) moved from $1.76 to $1.77, representing a gain of 0.68% ($0.01).
The stock traded between $0.97 and $3.48 during the period. The latest price is near the lower end of the 7-day range, indicating moderate upward.
The average daily volume was 195.39 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 1.1%
BCAB is currently trading at $1.77, placing it 1.1% of the way from its 52-week low of $0.97 to its 52-week high of $71.50. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
BIOATLA INC
| Exchange | NASDAQ |
Eligible investors can buy real shares of BioAtla, Inc. (BCAB) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.